SELECTIVE NATURAL κ OPIOID AND CANNABINOID RECEPTOR AGONISTS WITH A POTENTIAL ROLE IN THE TREATMENT OF GASTROINTESTINAL DYSFUNCTION

被引:18
|
作者
Fichna, Jakub [1 ]
Schicho, Rudolf [2 ]
Janecko, Anna [1 ]
Zjawiony, Jordan K. [3 ]
Storr, Martin [2 ]
机构
[1] Med Univ Lodz, Fac Med, Dept Biomol Chem, Lodz, Poland
[2] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB T2N 4N1, Canada
[3] Univ Mississippi, Sch Pharm, Dept Pharmacognosy, University, MS 38677 USA
关键词
SALVINORIN-A ANALOGS; IRRITABLE-BOWEL-SYNDROME; PLANT-DERIVED HALLUCINOGEN; HERB SALVIA-DIVINORUM; NEOCLERODANE DITERPENES; IN-VITRO; ENDOCANNABINOID SYSTEM; INDUCED HYPERMOTILITY; COLONIC INFLAMMATION; INDUCED INHIBITION;
D O I
10.1358/dnp.2009.22.7.1400219
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Salvinorin A is the major active ingredient of Salvia divinorum, a plant used by the Mazatec Indians of Mexico for spiritual and medical purposes. Different preparations from S. divinorum are also used in traditional heating practices to treat gastrointestinal disorders, including diarrhea. The recent extensive research on salvinorin A and other neoclerodane diterpenoids derived from S. divinorum resulted in a large number of reports describing their isolation, synthesis and structure-activity relationship. This review summarizes the present knowledge on salvinorin A and its analogues, with a focus on the effects on gastrointestinal tissues. We furthermore discuss structural changes in salvinorin A that may facilitate future use of its derivatives in human disease.
引用
收藏
页码:383 / 392
页数:10
相关论文
共 50 条
  • [41] Treatment of chronic allodynia in spinally injured rats: effects of intrathecal selective opioid receptor agonists
    Hao, JX
    Yu, W
    Wiesenfeld-Hallin, Z
    Xu, XJ
    PAIN, 1998, 75 (2-3) : 209 - 217
  • [42] Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists
    Grenald, Shaness A.
    Young, Madison A.
    Wang, Yue
    Ossipov, Michael H.
    Ibrahim, Mohab M.
    Largent-Milnes, Tally M.
    Vanderah, Todd W.
    NEUROPHARMACOLOGY, 2017, 116 : 59 - 70
  • [43] Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia
    Auh, Q-Schick
    Chun, Yang Hyun
    Melemedjian, Ohannes K.
    Zhang, Youping
    Ro, Jin Y.
    BRAIN RESEARCH BULLETIN, 2016, 125 : 211 - 217
  • [44] Cannabinoid receptor type 2 Agonists induce transcription of the μ-opioid receptor gene in Jurkat T cells
    Börner, C
    Höllt, V
    Kraus, J
    MOLECULAR PHARMACOLOGY, 2006, 69 (04) : 1486 - 1491
  • [45] Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases
    Nettekoven, Matthias
    Adam, Jean-Michel
    Bendels, Stefanie
    Bissantz, Catarina
    Fingerle, Juergen
    Grether, Uwe
    Gruener, Sabine
    Guba, Wolfgang
    Kimbara, Atsushi
    Ottaviani, Giorgio
    Puellmann, Bernd
    Rogers-Evans, Mark
    Roever, Stephan
    Rothenhaeusler, Benno
    Schmitt, Sebastien
    Schuler, Franz
    Schulz-Gasch, Tanja
    Ullmer, Christoph
    CHEMMEDCHEM, 2016, 11 (02) : 179 - 189
  • [46] Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: Impact of drug and fixed-dose ratio
    Maguire, David R.
    France, Charles P.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 819 : 217 - 224
  • [47] Interactions between μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists in Rhesus Monkeys: Antinociception, Drug Discrimination, and Drug Self-Administration
    Maguire, David R.
    Yang, Wenjuan
    France, Charles P.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 345 (03): : 354 - 362
  • [48] Novel azoles as potent and selective cannabinoid CB2 receptor agonists
    Harnett, Jeremiah J.
    Dolo, Christine
    Viossat, Isabelle
    Auger, Florence
    Ferrandis, Eric
    Bigg, Dennis
    Auguet, Michel
    Auvin, Serge
    Chabrier, Pierre-E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (01) : 88 - 91
  • [49] Opioid and cannabinoid receptor protein levels following chronic treatment
    Cichewicz, DL
    Welch, SP
    FASEB JOURNAL, 2001, 15 (04): : A228 - A228
  • [50] Role of cannabinoid receptor agonists in mechanisms of suppression of central pain syndrome
    M. L. Kukushkin
    S. I. Igon’kina
    M. V. Churyukanov
    V. V. Churyukanov
    M. Yu. Bobrov
    V. V. Bezuglov
    N. V. Gretskaya
    Bulletin of Experimental Biology and Medicine, 2006, 142 : 39 - 42